• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾滋病是处于HIV血清转化和死亡之间的一个浮点值吗?来自三大洲血清转化者研究的见解。

Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study.

作者信息

van Benthem B H, Veugelers P J, Cornelisse P G, Strathdee S A, Kaldor J M, Shafer K A, Coutinho R A, van Griensven G J

机构信息

Municipal Health Service, Division of Public Health and Environment, Amsterdam, The Netherlands.

出版信息

AIDS. 1998 Jun 18;12(9):1039-45.

PMID:9662201
Abstract

OBJECTIVE

To investigate the significance of the time from seroconversion to AIDS (incubation time) and other covariates for survival from AIDS to death.

METHODS

In survival analysis, survival from AIDS to death was compared for different categories of length of incubation time adjusted and unadjusted for other covariates, and significant predictors for survival from AIDS to death were investigated.

RESULTS

Survival after AIDS was not affected by the incubation time in univariate as well as in multivariate analyses. Predictive factors for progression from AIDS to death were age at seroconversion, type of AIDS diagnosis, and CD4 cell count at AIDS. The relative hazard for age at seroconversion increased 1.38-fold over 10 years. Men with a CD4 cell count at AIDS of <130 x 10(6)/l had a twofold higher risk in progression to death than men with higher CD4 cell counts. Persons diagnosed with lymphoma had a sixfold higher risk of progression to death than persons with Kaposi's sarcoma or opportunistic infections.

CONCLUSIONS

The incubation time as well as other factors before AIDS did not affect survival after AIDS. Survival from AIDS to death can be predicted by data obtained at the time of AIDS diagnosis, such as type of diagnosis, age and CD4 cell count. AIDS seems to be a significant point in progression to death, and not just a floating point between infection and death affected by prior factors for persons who did not receive effective therapy and did not have long incubation times.

摘要

目的

探讨从血清转化到艾滋病的时间(潜伏期)及其他协变量对从艾滋病到死亡生存情况的意义。

方法

在生存分析中,比较了对其他协变量进行调整和未调整的不同潜伏期类别下从艾滋病到死亡的生存情况,并研究了从艾滋病到死亡生存情况的显著预测因素。

结果

在单变量和多变量分析中,艾滋病后的生存情况均不受潜伏期的影响。从艾滋病进展到死亡的预测因素为血清转化时的年龄、艾滋病诊断类型以及艾滋病时的CD4细胞计数。血清转化时年龄的相对风险在10年内增加了1.38倍。艾滋病时CD4细胞计数<130×10⁶/L的男性进展至死亡的风险是CD4细胞计数较高男性的两倍。被诊断为淋巴瘤的人进展至死亡的风险是患卡波西肉瘤或机会性感染的人的六倍。

结论

艾滋病前的潜伏期以及其他因素不影响艾滋病后的生存情况。从艾滋病到死亡的生存情况可通过艾滋病诊断时获得的数据进行预测,如诊断类型、年龄和CD4细胞计数。艾滋病似乎是进展至死亡的一个重要节点,而不仅仅是未接受有效治疗且潜伏期不长的人在感染和死亡之间受先前因素影响的一个浮动点。

相似文献

1
Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study.艾滋病是处于HIV血清转化和死亡之间的一个浮点值吗?来自三大洲血清转化者研究的见解。
AIDS. 1998 Jun 18;12(9):1039-45.
2
Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.1986年至2001年一组注射吸毒者中从HIV血清转化发展为艾滋病及死亡的性别差异。
J Epidemiol Community Health. 2004 Nov;58(11):944-50. doi: 10.1136/jech.2003.017475.
3
[Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].[高效抗逆转录病毒疗法(HAART)引入前后HIV阳性个体的生存情况、进展为艾滋病及免疫抑制情况]
Epidemiol Prev. 2003 Nov-Dec;27(6):348-55.
4
Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.在高效抗逆转录病毒治疗时代,香港一组晚期1型艾滋病毒病患者的死亡和艾滋病进展延迟情况。
Clin Infect Dis. 2004 Sep 15;39(6):853-60. doi: 10.1086/423183. Epub 2004 Aug 27.
5
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.在高效抗逆转录病毒治疗广泛应用之前,从HIV-1血清转化到艾滋病及死亡的时间:一项合作重新分析。艾滋病潜伏期和HIV生存协作组,包括CASCADE欧盟协调行动。欧洲血清转化为艾滋病及死亡协调行动。
Lancet. 2000 Apr 1;355(9210):1131-7.
6
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.联合抗逆转录病毒治疗中断与临床疾病进展至艾滋病或死亡的风险。
HIV Med. 2007 Mar;8(2):96-104. doi: 10.1111/j.1468-1293.2007.00436.x.
7
Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.对有记录的HIV-1血清转化日期的注射吸毒者和男同性恋者中疾病进展与未进展情况的比较。欧洲血清转化者研究和三大洲血清转化者研究。
AIDS. 1997 Apr;11(5):621-31. doi: 10.1097/00002030-199705000-00010.
8
[Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].[人类免疫缺陷病毒1型病毒载量和CD4淋巴细胞计数作为艾滋病进展和生存决定因素的价值]
Med Clin (Barc). 1998 Jun 6;110(20):761-7.
9
Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.多重疱疹病毒感染对一组HIV血清转化者中HIV疾病进展的影响。
J Med Virol. 2003 Feb;69(2):182-7. doi: 10.1002/jmv.10281.
10
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load.意大利血清转化研究中1型人类免疫缺陷病毒的纵向载量:病毒载量的相关因素和时间趋势
J Infect Dis. 1999 Oct;180(4):1018-24. doi: 10.1086/314980.

引用本文的文献

1
Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
Eur J Epidemiol. 2000;16(7):633-9. doi: 10.1023/a:1007696530440.